推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

CELLULAR ONCOLOGY 期刊收藏夹

2025年3月最新中科院分区数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 最新评论:大佬有消息吗,审稿快不快 (2025-03-13)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
近期推荐:
SCI论文AI润色+人工QC服务
赛默飞基础学科研究有奖问卷
同行专家帮助选刊
Springer Nature特刊征稿
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


CELLULAR ONCOLOGY期刊基本信息Hello,您是该期刊的第39872位访客


基本信息 登录收藏
期刊名字CELLULAR ONCOLOGYCELLULAR ONCOLOGY


(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.6
53人评分
我要评分

声誉
7.8

影响力
5.5

速度
7.1

期刊ISSN1570-5870
微信扫码收藏此期刊
P-ISSN2211-3428
E-ISSN2211-3436
2023-2024最新影响因子
(数据来源于搜索引擎)
4.9 点击查看影响因子趋势图
实时影响因子 截止2025年5月19日:4.783
2023-2024自引率2.00%点击查看自引率趋势图
五年影响因子5.2
JCI期刊引文指标 1.17
h-index 暂无h-index数据
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
10.301.4891.031
学科分区排名百分位
大类:Medicine
小类:Oncology
Q156 / 404
大类:Medicine
小类:Molecular Medicine
Q132 / 178
大类:Medicine
小类:Cancer Research
Q148 / 230

期刊简介
The Official Journal of the International Society for Cellular Oncology
Focuses on translational research
Addresses the conversion of cell biology to clinical applications
Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions.

A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology forms a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologists and other clinicians involved in the management of cancer patients.
In vitro studies are preferentially supported by validations in tumor tissue with clinicopathological associations.
期刊官方网站https://www.springer.com/13402
期刊投稿格式模板
VIP专享
Word版格式模板 LaTeX版格式模板
此模板由LetPub整理,仅供参考。开通VIP可免费下载,并享1w+期刊模板资源。
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
期刊投稿网址https://www.editorialmanager.com/ceon
作者指南网址https://www.springer.com/13402/submission-guidelines
期刊语言要求Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CELLULAR ONCOLOGY的语言要求,还能让CELLULAR ONCOLOGY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CELLULAR ONCOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式IOS PRESS, NIEUWE HEMWEG 6B, AMSTERDAM, NETHERLANDS, 1013 BG
出版商Springer Netherlands
涉及的研究方向Biochemistry, Genetics and Molecular Biology-Cancer Research
出版国家或地区NETHERLANDS
出版语言English
出版周期Bimonthly
出版年份2011
年文章数 136点击查看年文章数趋势图
Gold OA文章占比29.94%
研究类文章占比:
文章 ÷(文章 + 综述)
80.15%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:CELL BIOLOGYSCIEQ267/205
学科:ONCOLOGYSCIEQ168/322
学科:PATHOLOGYSCIEQ111/88
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:CELL BIOLOGYSCIEQ144/205
学科:ONCOLOGYSCIEQ163/322
学科:PATHOLOGYSCIEQ116/88
中国科学院《国际期刊预警
名单(试行)》名单
2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2025年3月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区2区1区
ONCOLOGY
肿瘤学
1区4区2区
PATHOLOGY
病理学
2区2区2区
CELL BIOLOGY
细胞生物学
3区1区3区
中国科学院SCI期刊分区
2023年12月升级版
大类学科小类学科Top期刊综述期刊
医学 2区2区3区
CELL BIOLOGY
细胞生物学
1区2区2区
PATHOLOGY
病理学
2区2区2区
ONCOLOGY
肿瘤学
3区3区3区
中国科学院SCI期刊分区
2022年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区2区3区
PATHOLOGY
病理学
2区2区1区
CELL BIOLOGY
细胞生物学
2区2区2区
ONCOLOGY
肿瘤学
4区3区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1570-5870%5BISSN%5D
平均审稿速度网友分享经验:
16 Weeks
平均录用比例网友分享经验:
容易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在CELLULAR ONCOLOGY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
提交文稿
期刊常用信息链接
同领域相关期刊 CELLULAR ONCOLOGY期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 CELLULAR ONCOLOGY中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
CELLULAR ONCOLOGY上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Cancer Communications025.50
    Translational Oncology418.40
    Frontiers in Oncology606.20
    Journal of Gastric Cancer224.30
    Molecular and Cellular Oncology03.20
    Clinical and Experimental Morphology00.60
    Critical Reviews in Oncogenesis01.70
    International Journal of Medical Biochemistry00.50
    Advances in Cancer Biology Metastasis02.40
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE736156
    BIOMATERIALS609831
    BIOMEDICINE & PHARMACOTHERAPY603101
    Frontiers in Pharmacology568696
    COMPUTERS IN BIOLOGY AND MEDICINE557992
    Frontiers in Immunology554313
    JOURNAL OF ETHNOPHARMACOLOGY546541
    Frontiers in Oncology492627
    COLLOIDS AND SURFACES B-BIOINTERFACES467921
    Acta Biomaterialia457894
  •  

    CELLULAR ONCOLOGY CELLULAR ONCOLOGY
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.From benign neurofibromas to malignant peripheral nerve sheath tumors (MPNST): a gaming among multiple factors

    Author: Yu, Yanan; Wei, Chengjiang; Yue, Minghui; Zhang, Cheng; Wang, Yixiao; Wang, Zhichao
    Journal: CELLULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s13402-025-01054-9
        PubMed      DOI
    2.Sirtuin 3-mediated delactylation of malic enzyme 2 disrupts redox balance and inhibits colorectal cancer growth

    Author: Li, Chaoqun; Ge, Cun; Wang, Qingwen; Teng, Peng; Jia, Heyuan; Yao, Surui; Huang, Zhaohui
    Journal: CELLULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s13402-025-01058-5
        PubMed      DOI
    3.Tumor-specific CXCR6 positive precursor CD8+ T cells mediate tumor control in metastatic melanoma

    Author: Song, Yang; Chen, Ji; Zhang, Yaqin; Wu, Ning; Zhu, Yongjun; Chen, Gang; Miao, Feng; Chen, Zhiming; Wang, Yiqing
    Journal: CELLULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s13402-025-01040-1
        PubMed      DOI
    4.Trained immunity alleviates the progression of melanoma during sepsis-associated immunoparalysis

    Author: Yin, Lijie; Dong, Yue; Luo, Renjie; Li, Jingman; Wang, Jiali; Dou, Huan; Zhao, Guangfeng; Hou, Yayi
    Journal: CELLULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s13402-025-01063-8
        PubMed      DOI
    5.Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular carcinoma progression via the KCTD1/HIF-1α/VEGF pathway

    Author: Zhu, Xinyu; Li, Zhiwei; Chen, Li; Li, Limin; Ouyang, Mi; Zhou, Hao; Xiao, Kai; Lin, Ling; Chu, Paul K.; Zhou, Chang; Xun, Chengfeng; Yang, Liu; Huang, Wenhuan; Ding, Xiaofeng
    Journal: CELLULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s13402-025-01044-x
        PubMed      DOI
    6.THEMIS2 contributes to ovarian cancer metastasis via DOCK4-mediated activation of Rap1 signaling

    Author: Zhou, Kaixia; Ma, Xiaolu; Yan, Tianqing; Hu, Ling; Tian, Yanan; Zheng, Hui; Xie, Suhong; Tong, Ying; Wang, Yanchun; Guo, Lin; Lu, Renquan
    Journal: CELLULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s13402-025-01057-6
        PubMed      DOI
    7.HBO1 determines epithelial-mesenchymal transition and promotes immunotherapy resistance in ovarian cancer cells

    Author: Zhang, Cong; Zhu, Jinmin; Lin, Huaisong; Zhang, Zhishuai; Kang, Baoqiang; Li, Fei; Shan, Yongli; Zhang, Yanqi; Xing, Qi; Gu, Jiaming; Hu, Xing; Cui, Yuanbin; Huang, Jingxi; Zhou, Tiancheng; Mai, Yuchan; Chen, Qianyu; Mao, Rui; Li, Peng; Pan, Guangjin
    Journal: CELLULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s13402-025-01055-8
        PubMed      DOI
    8.Evaluating the prognostic significance of tumor deposits in gastric cancer and strategies for their integration into the TNM staging system: a single-center retrospective study

    Author: Yu, Jun; Yao, Ruirong; Han, Ning; Lu, Linbin; Chen, Ling; Reyila, Abudurousuli; Wang, Xinlin; Yan, Junya; Wang, Shibo; Guo, Yong; Zhao, Qingchuan; Wu, Kaichun; Lu, Yuanyuan; Ji, Gang; Li, Zengshan; Gao, Xianchun; Nie, Yongzhan
    Journal: CELLULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s13402-025-01046-9
        PubMed      DOI
    9.LPA released from dying cancer cells after chemotherapy inactivates Hippo signaling and promotes pancreatic cancer cell repopulation (Feb, 10.1007/s13402-025-01038-9, 2025)

    Author: Liu, Yuzhi; Ding, Jie; Li, Shumin; Jiang, Anyi; Chen, Zhiqin; Quan, Ming
    Journal: CELLULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s13402-025-01047-8
        PubMed      DOI
    10.UBE2Q2 promotes tumor progression and glycolysis of hepatocellular carcinoma through NF-κB/HIF1α signal pathway

    Author: Wu, Xiaoling; Chen, Yiran; He, Wenzhi; Yao, Ye; Liu, Yingyi; Xia, Peng; Zhang, Hao; Li, Xiaomian; Guo, Yonghua; Chen, Xi; Ma, Weijie; Yuan, Yufeng
    Journal: CELLULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s13402-025-01037-w
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    MMWR Recommendations and Reports036.00
    同分区等级的其他期刊名称 h-index CiteScore
    Kidney International Supplements2026.70
    Kidney International Supplements2426.70
    REPORTS ON PROGRESS IN PHYSICS18431.90
    SusMat00.00
    Computational Visual Media016.90
    Nano Energy11230.30
    Wiley Interdisciplinary Reviews-Computational Molecular Science6228.90
    NUCLEIC ACIDS RESEARCH45227.10
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE718.40
    Environmental Chemistry Letters5032.00
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共3


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2025 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室